2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial-Reference-Cited by-同舟云学术

2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial

Published:2021-10 Issue:10 Volume:5 Page:698-707
ISSN:2352-4642
Container-title:The Lancet Child & Adolescent Health
language:en
Short-container-title:The Lancet Child & Adolescent Health

Author:

Marlow Neil,Stahl Andreas,Lepore Domenico,Fielder Alistair,Reynolds James D,Zhu Qi,Weisberger Annemarie,Stiehl Daniel P,Fleck Brian

Funder

Novartis AG

Publisher

Elsevier BV

Subject

Developmental and Educational Psychology,Pediatrics, Perinatology, and Child Health

Reference38 articles.

1. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity;Mintz-Hittner;N Eng J Med,2011

2. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial;Stahl;Lancet,2019

3. Concerns for development after bevacizumab treatment of ROP;Quinn;Pediatrics,2016

4. Pharmacokinetics of bevacizumab and its effects on serum VEGF and IGF-1 in infants with retinopathy of prematurity;Kong;Invest Ophthalmol Vis Sci,2015

5. VEGF in the nervous system;Rosenstein;Organogenesis,2010

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Risk Factors for Retinopathy of Prematurity Reactivation after Intravitreal Antivascular Endothelial Growth Factor Injection;The Journal of Pediatrics;2024-10

2. Comparison of ranibizumab and conbercept treatment in type 1 prethreshold retinopathy of prematurity in zone II;BMC Pediatrics;2024-08-30

3. Safety and efficacy of ripasudil eye drops in preterm infants with retinopathy of prematurity: phase 1/2, open label, single-arm trial;Japanese Journal of Ophthalmology;2024-07-26

4. Comparison of Intravitreal Ranibizumab and Laser Photocoagulation in the Treatment of Type I Retinopathy of Prematurity in Malaysia: A One-Year Follow-Up Study;Cureus;2024-07-02

5. Aflibercept to treat retinopathy of prematurity: need for more research;Journal of Perinatology;2024-05-10